‘Political manipulation’: Trump admin alleges Chinese ‘biotech companies of concerns’ use ‘forced labor’ to source materials, barring imports

Feed excerpt — reported by Fortune

The latest trade actions precede an expected meeting next month between Chinese leader Xi Jinping and U.S. President Donald Trump.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at Fortune →

View MAP Context →